Buch-Bewertungen Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents -

Bewertung Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Springer-Verlag New York Inc.

0,00 € ^{inkl. MwSt.}

Beschreibung
Details

The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents. weiter lesen

Verlag: Springer-Verlag New York Inc.
Code:
Erscheinungsjahr: 2011
Sprache: Englisch
Einband: Taschenbuch
Seitenanzahl: 298

Zuletzt angesehen

0,00 € ^{inkl. MwSt.}
0,00 € ^{inkl. MwSt.}

Warenkorb

Bewertung Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Zuletzt angesehen

Handel

Für Kunden

Information

Zahlungssicherheit

MEGABUECHER.DE - Internet-Buchhandel